1. Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: A consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease;Ten;Eur Heart J,2021
2. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Otto;Circulation,2021
3. 2017 ESC/EACTS Guidelines for the management of valvular heart disease;Baumgartner;Eur Heart J,2017
4. A controlled trial of rivaroxaban after transcatheter aortic-valve replacement;Dangas;N Engl J Med,2020
5. Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation;Nijenhuis;N Engl J Med,2020